Rezultati - Weiyuan Chung

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Pomalidomide plus low‐dose dexamethasone in relapsed refractory multiple myeloma after lenalidomide treatment failure

    Pomalidomide plus low‐dose dexamethasone in relapsed refractory multiple myeloma after lenalidomide treatment failure od David S. Siegel, Gary J. Schiller, Kevin Song, Richy Agajanian, Keith Stockerl‐Goldstein, Hakan Kaya, Michaël Sébag, Christy Samaras, Ehsan Malek, Giampaolo Talamo, Christopher S. Seet, Jorge Mouro, William E. Pierceall, Faiza Zafar, Weiyuan Chung, Shankar Srinivasan, Amit Agarwal, Nizar J. Bahlis

    Izdano 2019
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment

    Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment od David S. Siegel, Gary J. Schiller, Christy Samaras, Michaël Sébag, Jesús G. Berdeja, Siddhartha Ganguly, Jeffrey Matous, Kevin Song, Christopher S. Seet, Giampaolo Talamo, Mirelis Acosta-Rivera, Michael Bär, Donald P. Quick, Bertrand Anz, Gustavo Fonseca, Donna Reece, William E. Pierceall, Weiyuan Chung, Faiza Zafar, Amit Agarwal, Nizar J. Bahlis

    Izdano 2020
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: